Literature DB >> 17658281

Transcription factor Pax5 activates the chromatin of key genes involved in B cell signaling, adhesion, migration, and immune function.

Alexandra Schebesta1, Shane McManus, Giorgia Salvagiotto, Alessio Delogu, Georg A Busslinger, Meinrad Busslinger.   

Abstract

The transcription factor Pax5 represses B lineage-inappropriate genes and activates B cell-specific genes in B lymphocytes. Here we have identified 170 Pax5-activated genes. Conditional mutagenesis demonstrated that the Pax5-regulated genes require continuous Pax5 activity for normal expression in pro-B and mature B cells. Expression of half of the Pax5-activated genes is either absent or substantially reduced upon Pax5 loss in plasma cells. Direct Pax5 target genes were identified based on their protein synthesis-independent activation by a Pax5-estrogen receptor fusion protein. Chromatin immunoprecipitation (ChIP) of Pax5 together with chromatin profiling by ChIP-on-chip analysis demonstrated that Pax5 directly activates the chromatin at promoters or putative enhancers of Pax5 target genes. The Pax5-activated genes code for key regulatory and structural proteins involved in B cell signaling, adhesion, migration, antigen presentation, and germinal-center B cell formation, thus revealing a complex regulatory network that is activated by Pax5 to control B cell development and function.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17658281     DOI: 10.1016/j.immuni.2007.05.019

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  113 in total

1.  Quantitative modeling of the terminal differentiation of B cells and mechanisms of lymphomagenesis.

Authors:  María Rodríguez Martínez; Alberto Corradin; Ulf Klein; Mariano Javier Álvarez; Gianna M Toffolo; Barbara di Camillo; Andrea Califano; Gustavo A Stolovitzky
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

2.  The orchestration of mammalian tissue morphogenesis through a series of coherent feed-forward loops.

Authors:  Qing Xie; Ales Cvekl
Journal:  J Biol Chem       Date:  2011-10-13       Impact factor: 5.157

3.  The B-cell identity factor Pax5 regulates distinct transcriptional programmes in early and late B lymphopoiesis.

Authors:  Roger Revilla-I-Domingo; Ivan Bilic; Bojan Vilagos; Hiromi Tagoh; Anja Ebert; Ido M Tamir; Leonie Smeenk; Johanna Trupke; Andreas Sommer; Markus Jaritz; Meinrad Busslinger
Journal:  EMBO J       Date:  2012-06-05       Impact factor: 11.598

4.  Common clonal origin of an acute B-lymphoblastic leukemia and a Langerhans' cell sarcoma: evidence for hematopoietic plasticity.

Authors:  Richard Ratei; Michael Hummel; Ioannis Anagnostopoulos; Doris Jähne; Renate Arnold; Bernd Dörken; Stephan Mathas; Thomas Benter; Oliver Dudeck; Wolf-Dieter Ludwig; Harald Stein
Journal:  Haematologica       Date:  2010-04-26       Impact factor: 9.941

5.  Bach2: plasma-cell differentiation takes a break.

Authors:  Axel Kallies; Stephen L Nutt
Journal:  EMBO J       Date:  2010-12-01       Impact factor: 11.598

Review 6.  Extrinsic and intrinsic regulation of early natural killer cell development.

Authors:  Markus D Boos; Kevin Ramirez; Barbara L Kee
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

Review 7.  Maintaining differentiated cellular identity.

Authors:  Johan Holmberg; Thomas Perlmann
Journal:  Nat Rev Genet       Date:  2012-05-18       Impact factor: 53.242

8.  Pax-5 Inhibits NF-κB Activity in Breast Cancer Cells Through IKKε and miRNA-155 Effectors.

Authors:  Jason Harquail; Nicolas LeBlanc; Carine Landry; Nicolas Crapoulet; Gilles A Robichaud
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-07-21       Impact factor: 2.673

9.  Attenuation of antigenic immunogenicity by kynurenine, a novel suppressive adjuvant.

Authors:  Zhiqing Duan; Yunqing Duan; Huangui Lei; Ningzhu Hu; Jiandong Shi; Dong Shen; Xi Wang; Yunzhang Hu
Journal:  Hum Vaccin Immunother       Date:  2014-02-28       Impact factor: 3.452

10.  PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia.

Authors:  Zhaohui Gu; Michelle L Churchman; Kathryn G Roberts; Ian Moore; Xin Zhou; Joy Nakitandwe; Kohei Hagiwara; Stephane Pelletier; Sebastien Gingras; Hartmut Berns; Debbie Payne-Turner; Ashley Hill; Ilaria Iacobucci; Lei Shi; Stanley Pounds; Cheng Cheng; Deqing Pei; Chunxu Qu; Scott Newman; Meenakshi Devidas; Yunfeng Dai; Shalini C Reshmi; Julie Gastier-Foster; Elizabeth A Raetz; Michael J Borowitz; Brent L Wood; William L Carroll; Patrick A Zweidler-McKay; Karen R Rabin; Leonard A Mattano; Kelly W Maloney; Alessandro Rambaldi; Orietta Spinelli; Jerald P Radich; Mark D Minden; Jacob M Rowe; Selina Luger; Mark R Litzow; Martin S Tallman; Janis Racevskis; Yanming Zhang; Ravi Bhatia; Jessica Kohlschmidt; Krzysztof Mrózek; Clara D Bloomfield; Wendy Stock; Steven Kornblau; Hagop M Kantarjian; Marina Konopleva; Williams E Evans; Sima Jeha; Ching-Hon Pui; Jun Yang; Elisabeth Paietta; James R Downing; Mary V Relling; Jinghui Zhang; Mignon L Loh; Stephen P Hunger; Charles G Mullighan
Journal:  Nat Genet       Date:  2019-01-14       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.